These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12079189)

  • 1. Characterization and implications of bioassay variation.
    Ostland M
    Dev Biol (Basel); 2002; 107():3-10. PubMed ID: 12079189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing bioassay variability by identifying sources of variation and controlling key parameters in assay protocol.
    Ren S; Frymier PD
    Chemosphere; 2004 Oct; 57(2):81-90. PubMed ID: 15356920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Setting specifications for potency assays--basic principles.
    Mire-Sluis AR
    Dev Biol (Basel); 2002; 107():107-15. PubMed ID: 12079184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel line bioassay in practice. Practical aspects of design, analysis, and regulatory requirements from the technician's point of view.
    Norwood BJ
    Dev Biol (Basel); 2002; 107():57-62. PubMed ID: 12079192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected topics in parallel line bioassay.
    Giltinan D
    Dev Biol (Basel); 2002; 107():47-56. PubMed ID: 12079191
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of the EU-harmonised mouse bioassay for lipophilic toxins for the detection of azaspiracids in naturally contaminated mussel (Mytilus edulis) hepatopancreas tissue homogenates characterised by liquid chromatography coupled to tandem mass spectrometry.
    Hess P; Butter T; Petersen A; Silke J; McMahon T
    Toxicon; 2009 Jun; 53(7-8):713-22. PubMed ID: 19254738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The statistical performance of an MCF-7 cell culture assay evaluated using generalized linear mixed models and a score test.
    Rey deCastro B; Neuberg D
    Stat Med; 2007 May; 26(12):2501-18. PubMed ID: 17109375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case study: development of a bioassay for IL-1ra.
    Wolf J
    Dev Biol (Basel); 2002; 107():63-7. PubMed ID: 12079193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating relative potency using prior information.
    Kim PT; Carter EM; Hubert JJ
    Biometrics; 1991 Mar; 47(1):295-301. PubMed ID: 2049503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strip-plot designs, mixed models, and comparisons between linear and non-linear models for microtitre plate bioassays.
    Lansky D
    Dev Biol (Basel); 2002; 107():11-23. PubMed ID: 12079185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The minimum significant ratio: a statistical parameter to characterize the reproducibility of potency estimates from concentration-response assays and estimation by replicate-experiment studies.
    Eastwood BJ; Farmen MW; Iversen PW; Craft TJ; Smallwood JK; Garbison KE; Delapp NW; Smith GF
    J Biomol Screen; 2006 Apr; 11(3):253-61. PubMed ID: 16490778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of cytokines by bioassays: theory and application.
    Meager A
    Methods; 2006 Apr; 38(4):237-52. PubMed ID: 16481200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure variability: concepts and applications in occupational epidemiology.
    Loomis D; Kromhout H
    Am J Ind Med; 2004 Jan; 45(1):113-22. PubMed ID: 14691975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
    Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
    J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical approaches to specification setting with application to bioassay.
    Dillard RF
    Dev Biol (Basel); 2002; 107():117-27. PubMed ID: 12079186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response criteria for the bioassay of vitamin K.
    Bliss CI; Griminger P
    Biometrics; 1969 Dec; 25(4):735-45. PubMed ID: 5362287
    [No Abstract]   [Full Text] [Related]  

  • 18. Ensuring quality of in vitro alternative test methods: Current practice.
    Rispin A; Stitzel K; Harbell J; Klausner M
    Regul Toxicol Pharmacol; 2006 Jul; 45(2):97-103. PubMed ID: 16644076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant information in bioassay and semi-parametric estimation.
    Kim PT; Lee CH
    Stat Med; 2005 May; 24(9):1421-33. PubMed ID: 15568193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the simultaneous bioassay analysis method used for an intake estimation of a radionuclide.
    Lee JI; Lee JK
    Radiat Prot Dosimetry; 2007; 127(1-4):430-4. PubMed ID: 17893079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.